MARKET INSIGHTS
The Global Vitamin B3 market was valued at USD 803 million in 2024 and is projected to grow from USD 845 million in 2025 to USD 1,128 million by 2034, exhibiting a compound annual growth rate (CAGR) of 5.1% during the forecast period.
Vitamin B3, also known as niacin or nicotinic acid, is an essential water‑soluble nutrient that plays a critical role in metabolic processes. It functions as a precursor to coenzymes NAD and NADP, which are vital for energy production and cellular repair. The vitamin exists in multiple forms, including feed‑grade, medical‑grade, and other specialized formulations tailored for different applications.
The market expansion is driven by increasing demand from the feed industry, which accounts for over 67% of total consumption. However, the pharmaceutical and food sectors are also contributing to growth, fueled by rising health awareness and regulatory support. Europe currently leads the market with a 33% share, followed by North America and Asia‑Pacific. Key players such as Lonza, Jubilant Pharmova, and Vertellus dominate the competitive landscape, collectively holding 51% of the market share.
Vitamin B3 Market – View in Detailed Research Report
🌍 Outlook: The Future of Vitamin B3 Market
The Global Vitamin B3 market is poised for steady growth, projected to reach USD 1,128 million by 2034 at a 5.1% CAGR. The feed sector remains the primary growth driver, accounting for more than 67% of total consumption. Rising health consciousness, expanding pharmaceutical applications, and the adoption of sustainable production methods are further propelling the market.
📈 Key Trends Shaping the Market:
- Increasing demand for feed‑grade Vitamin B3 driven by intensive livestock farming.
- Expansion of pharmaceutical applications, especially in lipid regulation and dermatology.
- Adoption of green chemistry and bio‑based production to reduce energy consumption and waste.
- Emerging markets in Asia‑Pacific and Latin America creating new growth avenues.
- Precision nutrition and nutrigenomics driving demand for specialized formulations.
Top 10 Companies in the Vitamin B3 Market (2026)
1️⃣ Lonza Group AG
Headquarters: Basel, Switzerland
Key Offering: Feed‑grade and medical‑grade Vitamin B3, proprietary synthesis technologies
Lonza leads the Global Vitamin B3 industry with an estimated 18‑20% market share in 2024, leveraging its vertically integrated production capabilities and extensive distribution network across Europe and North America.
Sustainability & Growth Initiatives:
- Invested USD 150 million in green chemistry pilot plants (2024‑2026).
- Expanded European production capacity by 20% in 2023.
- Developed bio‑based synthesis routes reducing energy use by 25%.
2️⃣ Jubilant Pharmova Limited
Headquarters: Bengaluru, India
Key Offering: Pharmaceutical‑grade Vitamin B3, custom formulations for lipid therapy
Jubilant Pharmova’s strong foothold in the pharmaceutical sector, coupled with its expanding feed‑grade production, positions it as a key market player with ≈15% market share.
Sustainability & Growth Initiatives:
- Launched a new manufacturing facility in Southeast Asia (2023).
- Implemented waste‑reduction protocols cutting hazardous waste by 30%.
- Invested in R&D for extended‑release niacin formulations.
3️⃣ Vertellus Holdings LLC
Headquarters: New York, USA
Key Offering: Feed‑grade and medical‑grade Vitamin B3, specialty formulations
Vertellus, with a combined ≈15% market share alongside Jubilant Pharmova, focuses on high‑margin specialty products and has recently commissioned a new plant in Southeast Asia.
Sustainability & Growth Initiatives:
- Adopted continuous‑flow synthesis reducing raw‑material consumption by 20%.
- Partnered with local universities for nutrigenomics research.
- Implemented ISO 14001 environmental management system.
4️⃣ Brother Enterprises Holding Co., Ltd.
Headquarters: Shanghai, China
Key Offering: Feed‑grade Vitamin B3, cost‑competitive production
Brother Enterprises commands a significant share of the Asian feed‑grade market, leveraging domestic raw‑material supply and government support.
Sustainability & Growth Initiatives:
- Invested in bio‑based precursor production.
- Implemented energy‑efficient manufacturing processes.
- Collaborated with local feed producers for technology transfer.
5️⃣ Zhejiang Lanbo Biotechnology Co., Ltd.
Headquarters: Hangzhou, China
Key Offering: Medical‑grade Vitamin B3, specialty nicotinamide derivatives
Lanbo’s focus on high‑quality medical‑grade products has earned it a strong foothold in the pharmaceutical segment.
Sustainability & Growth Initiatives:
- Developed green synthesis routes for nicotinamide.
- Invested in waste‑recycling infrastructure.
- Partnered with research institutes for nutraceutical development.
6️⃣ Lasons India Pvt. Ltd.
Headquarters: Mumbai, India
Key Offering: Feed‑grade Vitamin B3, value‑added formulations
Lasons India serves the growing Indian feed market with cost‑effective, high‑purity products.
Sustainability & Growth Initiatives:
- Implemented lean manufacturing reducing waste by 15%.
- Invested in renewable energy for plant operations.
- Collaborated with local feed cooperatives for distribution.
7️⃣ DSM Nutritional Products
Headquarters: The Hague, Netherlands
Key Offering: Nicotinamide derivatives, functional food ingredients
DSM’s focus on nutraceuticals and functional foods positions it strongly in the medical‑grade segment.
Sustainability & Growth Initiatives:
- Invested in bio‑based production of nicotinamide (2024).
- Reduced CO₂ emissions by 18% through process optimization.
- Engaged in circular economy projects for waste valorization.
8️⃣ Mianyang Vanatta Chemical Industrial Co.
Headquarters: Mianyang, China
Key Offering: Feed‑grade Vitamin B3, bulk production
Vanatta’s large‑scale manufacturing supports the growing demand in Asia‑Pacific.
Sustainability & Growth Initiatives:
- Adopted continuous‑flow synthesis to improve efficiency.
- Implemented waste‑recycling programs.
- Invested in local community development projects.
9️⃣ Tianjin Zhongrui Pharmaceutical Co., Ltd.
Headquarters: Tianjin, China
Key Offering: Pharmaceutical‑grade Vitamin B3, specialty formulations for dyslipidemia
Zhongrui focuses on high‑purity products for the medical sector.
Sustainability & Growth Initiatives:
- Implemented green chemistry protocols.
- Reduced energy consumption by 12% through process upgrades.
- Collaborated with academic institutions for clinical research.
🔟 Cargill Inc.
Headquarters: Chicago, USA
Key Offering: Feed‑grade Vitamin B3, integrated feed solutions
Cargill’s extensive feed portfolio and global distribution network reinforce its market position.
Sustainability & Growth Initiatives:
- Invested USD 200 million in sustainable feed production (2024‑2026).
- Reduced greenhouse gas emissions by 20% across feed manufacturing.
- Partnered with NGOs for animal nutrition education.
Download FREE Sample Report: Vitamin B3 Market – View in Detailed Research Report
Get Full Report: Vitamin B3 Market – View in Detailed Research Report
- Top 10 Companies in the R-452B Market (2026): Market Leaders Powering Global Innovation - June 30, 2026
- Top 10 Companies in the Global Ultra High Purity (UHP) Plastic Tubing for Semiconductor Market (2026): Market Leaders Powering the Future of Semiconductor Manufacturing - June 30, 2026
- Top 10 Companies in the Puerariae (Kudzuvine Root) Extract Market (2026): Market Leaders Powering Global Wellness - June 30, 2026
